Concepedia

Olga V. Zubkova

OV

Statistics

Publications

20

Citations

3.6K

H-Index

16

Active since

2008

Affiliations

Ministry of Health of the Russian Federation(Current)

Sechenov University

Peoples' Friendship University of Russia

Research Institute of Influenza

Russian Academy of Sciences

Olga V. Zubkova is an author at Ministry of Health of the Russian Federation specializing in infectious diseases, vaccinology, and vaccination.

ORCID

Publications per year

2008–2024

20

Publications

20

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov, Inna V. Dolzhikova, Dmitry V. Shcheblyakov et al. · The Lancet · 2021 · 1.8K citations · Full text

, , +16

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Denis Y. Logunov, Inna V. Dolzhikova, Olga V. Zubkova et al. · The Lancet · 2020 · 1.1K citations · Full text

, , +14

Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia

Inna V. Dolzhikova, Olga V. Zubkova, Amir I. Tukhvatulin et al. · Human Vaccines & Immunotherapeutics · 2017 · 133 citations · Full text

, , +17

Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants

Vladimir А. Gushchin, Inna V. Dolzhikova, Andrei E. Siniavin et al. · Vaccines · 2021 · 119 citations · Full text

, , +14

Mycoplasma infection suppresses p53, activates NF-κB and cooperates with oncogenic Ras in rodent fibroblast transformation

Denis Y. Logunov, D. V. Scheblyakov, Olga V. Zubkova et al. · Oncogene · 2008 · 79 citations · Full text

, , +14

1–5 of 20